Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| SOLAZYME INC | 218 403 | déclaré | 09 mars 2017 | tx 118+1 618 638−623 157 |
| Oruka Therapeutics, Inc. | 31 767 | déclaré | 16 mars 2026 | tx 4+325 000−733 |
| CymaBay Therapeutics, Inc. | 0 | déclaré | 22 mars 2024 | tx 49+1 367 499−981 054 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 16 mars 2026 | SALE | Oruka Therapeutics, Inc. | 733 | 41.30 USD | |
| 23 janv. 2026 | GRANT_AWARD | Oruka Therapeutics, Inc. | 32 500 | 0.00 USD | |
| 23 janv. 2026 | GRANT_AWARD | Oruka Therapeutics, Inc. | 130 000 | 0.00 USD | deriv |
| 22 janv. 2025 | GRANT_AWARD | Oruka Therapeutics, Inc. | 162 500 | 0.00 USD | deriv |
| 22 mars 2024 | OTHER | CymaBay Therapeutics, Inc. | 28 438 | — | |
| 22 mars 2024 | OTHER | CymaBay Therapeutics, Inc. | 41 824 | — | |
| 22 mars 2024 | OTHER | CymaBay Therapeutics, Inc. | 22 167 | — | deriv |
| 22 mars 2024 | OTHER | CymaBay Therapeutics, Inc. | 215 000 | — | deriv |
| 22 mars 2024 | OTHER | CymaBay Therapeutics, Inc. | 105 625 | — | deriv |
| 22 mars 2024 | OTHER | CymaBay Therapeutics, Inc. | 233 176 | — | deriv |
| 22 mars 2024 | OTHER | CymaBay Therapeutics, Inc. | 107 000 | — | deriv |
| 13 mars 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 41 824 | 7.89 USD | |
| 13 mars 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 41 824 | 0.00 USD | deriv |
| 24 janv. 2024 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 28 438 | 0.00 USD | |
| 24 janv. 2024 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 105 625 | 0.00 USD | deriv |
| 16 janv. 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 5 000 | 2.94 USD | |
| 16 janv. 2024 | SALE | CymaBay Therapeutics, Inc. | 5 000 | 23.58 USD | |
| 16 janv. 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 5 000 | 0.00 USD | deriv |
| 15 déc. 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 5 000 | 2.94 USD | |
| 15 déc. 2023 | SALE | CymaBay Therapeutics, Inc. | 5 000 | 21.98 USD | |
| 15 déc. 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 5 000 | 0.00 USD | deriv |
| 15 nov. 2023 | SALE | CymaBay Therapeutics, Inc. | 5 000 | 17.38 USD | |
| 15 nov. 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 5 000 | 2.94 USD | |
| 15 nov. 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 5 000 | 0.00 USD | deriv |
| 16 oct. 2023 | SALE | CymaBay Therapeutics, Inc. | 5 000 | 13.76 USD |